Contact Us
  Search
The Business Research Company Logo
Xenotransplantation Market Report 2026
Buy Now
Global Xenotransplantation Market Report 2026
Published :January 2026
Pages :150
Format :PDF
Delivery Time :2-3 Business Days
Why 2-3 days? We update the report with the latest data and news before delivery. Let us know if you need us to expedite.
Report Price :$4,490.00

Xenotransplantation Market Report 2026

Global Outlook – By Product (Organ Preservation Solutions, Transplant Diagnostics, Tissue Products), By Treatment (Analgesic, Immunosuppressant, Other Treatments), By Applications (Heart, Kidney, Other Organs), By End-User (Hospitals, Transplant Centers, Other End-Users) - Market Size, Trends, And Global Forecast 2026-2035

Xenotransplantation Market Overview

• Xenotransplantation market size has reached to $15.77 billion in 2025 • Expected to grow to $23.51 billion in 2030 at a compound annual growth rate (CAGR) of 8.2% • Growth Driver: Role Of Increase In Demand For Tissue And Organ Transplantation On Xenotransplantation Market • Market Trend: Strategic Partnership For Advancing Xenotransplantation With Karius And Egenesis Join Forces To Address Organ Shortage • North America was the largest region in 2025.
Research Expert

Book your 30 minutes free consultation with our research experts

What Is Covered Under Xenotransplantation Market?

Xenotransplantation is a procedure in which live nonhuman animal cells, tissues, or organs are transplanted, implanted, or infused into a human recipient. It also involves the transplantation, implantation, or infusion of human body fluids, cells, tissues, or organs after having had ex vivo contact with living nonhuman animal cells, tissues, or organs. The main products of xenotransplantation are organ preservation solutions, transplant diagnostics, and tissue products. The organ preservation solutions reduce ischemic and hypoxic damage during cold storage and enhance graft survival. Organ preservation techniques such as machine perfusion, in situ core cooling, and organ preservation fluids are all included in this field. Treatments for xenotransplantation include analgesics, immunosuppressants, and other treatments that apply to the heart, kidney, and other organs. The end-users of xenotransplantation include hospitals, transplant centers, and other end-users.
Xenotransplantation Market Global Report 2026 Market Report bar graph

What Is The Xenotransplantation Market Size and Share 2026?

The xenotransplantation market size has grown strongly in recent years. It will grow from $15.77 billion in 2025 to $17.13 billion in 2026 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to advancements in organ preservation science, shortage of human donor organs, progress in immunosuppressive therapies, early-stage xenograft research programs, development of transplant diagnostic technologies.

What Is The Xenotransplantation Market Growth Forecast?

The xenotransplantation market size is expected to see strong growth in the next few years. It will grow to $23.51 billion in 2030 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to increasing clinical trial activity in xenotransplantation, rising investments in gene-editing technologies, growing collaboration between biotech firms and hospitals, expansion of ethical and regulatory acceptance, increasing demand for alternative organ sources. Major trends in the forecast period include increasing research in genetically modified donor organs, growing focus on immune rejection mitigation, expansion of advanced organ preservation technologies, rising investment in translational transplant research, improved regulatory frameworks for clinical trials.

Global Xenotransplantation Market Segmentation

1) By Product: Organ Preservation Solutions, Transplant Diagnostics, Tissue Products 2) By Treatment: Analgesic, Immunosuppressant, Other Treatments 3) By Applications: Heart, Kidney, Other Organs 4) By End-User: Hospitals, Transplant Centers, Other End-Users Subsegments: 1) By Organ Preservation Solutions: Hypothermic Preservation Solutions, Normothermic Preservation Solutions, Organ Storage Solutions 2) By Transplant Diagnostics: Pre-Transplant Compatibility Testing, Post-Transplant Monitoring, Molecular Diagnostics 3) By Tissue Products: Xenograft Tissue Products, Tissue Engineered Products, Biological Scaffolds

What Is The Driver Of The Xenotransplantation Market?

The increase in demand for tissue and organ transplantation is expected to propel the xenotransplantation market. A hereditary disorder like polycystic kidney disease, cystic fibrosis, or a heart malfunction might lead to the need for an organ transplant in a large number of people. The high demand for organ transplants has led to a shortage of organs. Xenotransplantation helps deal with this shortage by using nonhuman organs instead of human organs. For instance, in January 2024, according to the Organ Procurement and Transplantation Network, a US-based Department of Health and Human Services program responsible for overseeing the nation’s organ donation and transplantation system, organ transplants from living and deceased donors totalled 46,632 in 2023, reflecting an 8.7 percent increase compared with 2022. Of these, 39,679 procedures were from deceased donors, representing an 8.9 percent rise over the previous year. Therefore, the increasing demand for tissue and organ transplantation will drive the xenotransplantation industry.

Key Players In The Global Xenotransplantation Market

Major companies operating in the xenotransplantation market are United Therapeutics, Preservation Solutions, OrganOX Limited, Talaris Therapeutics, TransMedic Inc., Sernova Corp, Nova Lung, Recombinetics, Tissue Regenix, TissueGene, SAB Biotherapeutics, eGenesis, Revivicor, Organ Recovery Systems, CRISPR Therapeutics, Qihan Biotech, Sino-Clone Organ Biotechnology, Xenothera, Lung Biotechnology.

What Are Latest Mergers And Acquisitions In The Xenotransplantation Market?

In October 2023, United Therapeutics Corporation, a US-based biotechnology company, acquired Miromatrix Medical for $91 million. This acquisition aims to increase the scope of its ongoing organ production initiatives, including xenotransplantation, 3-D bioprinting, x-vivo lung perfusion, and regenerative medicine techniques. Miromatrix Medical is a US-based development-stage, fully implantable, manufactured kidney product.

Regional Outlook

North America was the largest region in the xenotransplantation market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Need data on a specific region in this market?

What Defines the Xenotransplantation Market?

The xenotransplantation market includes revenues earned by entities by providing transplantation and diagnostics. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Xenotransplantation Market Report 2026?

The xenotransplantation market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the xenotransplantation industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Xenotransplantation Market Report Forecast Analysis

Report Attribute Details
Market Size Value In 2026$17.13 billion
Revenue Forecast In 2035$23.51 billion
Growth RateCAGR of 8.6% from 2026 to 2035
Base Year For Estimation2025
Actual Estimates/Historical Data2020-2025
Forecast Period2026 - 2030 - 2035
Market RepresentationRevenue in USD Billion and CAGR from 2026 to 2035
Segments CoveredProduct, Treatment, Applications, End-User
Regional ScopeAsia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country ScopeThe countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies ProfiledUnited Therapeutics, Preservation Solutions, OrganOX Limited, Talaris Therapeutics, TransMedic Inc., Sernova Corp, Nova Lung, Recombinetics, Tissue Regenix, TissueGene, SAB Biotherapeutics, eGenesis, Revivicor, Organ Recovery Systems, CRISPR Therapeutics, Qihan Biotech, Sino-Clone Organ Biotechnology, Xenothera, Lung Biotechnology.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Frequently Asked Questions

The Xenotransplantation market was valued at $15.77 billion in 2025, increased to $17.13 billion in 2026, and is projected to reach $23.51 billion by 2030.
The global Xenotransplantation market is expected to grow at a CAGR of 8.2% from 2026 to 2035 to reach $23.51 billion by 2035.
Some Key Players in the Xenotransplantation market Include, United Therapeutics, Preservation Solutions, OrganOX Limited, Talaris Therapeutics, TransMedic Inc., Sernova Corp, Nova Lung, Recombinetics, Tissue Regenix, TissueGene, SAB Biotherapeutics, eGenesis, Revivicor, Organ Recovery Systems, CRISPR Therapeutics, Qihan Biotech, Sino-Clone Organ Biotechnology, Xenothera, Lung Biotechnology. .
Major trend in this market includes: Strategic Partnership For Advancing Xenotransplantation With Karius And Egenesis Join Forces To Address Organ Shortage. For further insights on this market.
Request for Sample
North America was the largest region in the xenotransplantation market in 2025. The regions covered in the xenotransplantation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Research Expert

Book your 30 minutes free consultation with our research experts

Chat with us